Evidence map›Paper›PMID 32194852›Full record

ArticleTheranostics2020

Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform.

María Garranzo-Asensio, Ana Guzmán-Aránguez, Eloy Povedano, Víctor Ruiz-Valdepeñas Montiel, Carmen Poves, María Jesús Fernandez-Aceñero, Ana Montero-Calle, Guillermo Solís-Fernández, Servando Fernandez-Diez, Jordi Camps and 10 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Recent biomedical advances enabled by HaloTag technology.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2022
    Article
  13. Autoimmune Responses in Oncology: Causes and Significance.International journal of molecular sciences · 2021
    Review
  14. Phage Microarrays for Screening of Humoral Immune Responses.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

María Garranzo-AsensioDepartamento de Bioquímica y Biología Molecular, Facultad de Óptica y Optometría, Universidad Complutense de Madrid, 28037 Madrid, Spain.
Ana Guzmán-AránguezDepartamento de Bioquímica y Biología Molecular, Facultad de Óptica y Optometría, Universidad Complutense de Madrid, 28037 Madrid, Spain.
Eloy PovedanoDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Víctor Ruiz-Valdepeñas MontielDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Carmen PovesGastroenterology Unit, Hospital Universitario Clínico San Carlos, E-28040, Madrid, Spain.
María Jesús Fernandez-AceñeroPathology Department, University Hospital Gregorio Marañon, E-28007 Madrid, Spain.
Ana Montero-CalleUFIEC, Chronic Disease Programme, Instituto de Salud Carlos III, Majadahonda 28220, Madrid, Spain.
Guillermo Solís-FernándezUFIEC, Chronic Disease Programme, Instituto de Salud Carlos III, Majadahonda 28220, Madrid, Spain.
Servando Fernandez-DiezGastroenterology Unit, Hospital Universitario Clínico San Carlos, E-28040, Madrid, Spain.
Jordi CampsUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d´Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus (Spain).
Meritxell ArenasUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d´Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus (Spain).
Elisabeth Rodríguez-TomàsUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d´Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus (Spain).
Jorge JovenUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d´Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus (Spain).
Maricruz Sanchez-MartinezUFIEC, Chronic Disease Programme, Instituto de Salud Carlos III, Majadahonda 28220, Madrid, Spain.
Nuria RodriguezMedical Oncology Department, Hospital Universitario La Paz, E-28046, Madrid, Spain.
Gemma DominguezDepartamento de Medicina, Facultad de Medicina, Instituto de Investigaciones Biomédicas "Alberto Sols", CSIC-UAM, E-28029, Madrid, Spain.
Paloma Yáñez-SedeñoDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
José Manuel PingarrónDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Susana CampuzanoDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Rodrigo BarderasUFIEC, Chronic Disease Programme, Instituto de Salud Carlos III, Majadahonda 28220, Madrid, Spain.
Universidad Complutense de Madrid · ESHospital Clínico San Carlos · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario La Paz · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biosensing TechniquesAntibodies, NeoplasmAntibody SpecificityAntigens, NeoplasmArea Under CurveAsymptomatic DiseasesAutoantibodiesBiomarkers, TumorBreast NeoplasmsColorectal NeoplasmsElectrochemical TechniquesElectrodesFemaleHumansHydroquinonesImmobilized ProteinsAntibodies, NeoplasmAntigens, NeoplasmAutoantibodiesBiomarkers, TumorhydroquinoneHydroquinonesImmobilized ProteinsRecombinant Fusion Proteinsbiosensorcolorectal cancerearly cancer detectionelectrochemical bioplatformshalotag fusion proteinsliquid biopsy

Identifiers

PMID32194852
PMCPMC7053203
OpenAlexW3006282231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.